Financial Summary (All financials)
| In millions, except per share items | Jan-01-23 | Jan-02-22 | Jan-03-21 | Dec-29-19 | Dec-30-18 | Dec-31-17 | Jan-01-17 | Jan-03-16 |
| Revenues | 16.2 | 12.7 | 8.6 | 10.3 | 12.6 | 12.1 | 11.4 | 19.0 |
| Revenue growth | 27.6% | 46.9% | -16.3% | -18.4% | 4.0% | 6.4% | -39.7% | -31.9% |
| Cost of goods sold | 7.4 | 5.3 | 4.4 | 4.4 | 6.3 | 6.6 | 7.6 | 11.4 |
| Gross profit | 8.8 | 7.4 | 4.2 | 5.9 | 6.3 | 5.5 | 3.8 | 7.5 |
| Gross margin | 54.4% | 58.5% | 49.2% | 57.3% | 50.2% | 45.5% | 33.0% | 39.8% |
| Selling, general and administrative | 7.5 | 8.0 | 6.8 | 8.9 | 10.0 | 9.9 | 10.3 | 10.6 |
| Research and development | 5.0 | 6.9 | 7.5 | 12.4 | 9.9 | 9.6 | 12.3 | 14.1 |
| EBIT | -3.7 | -7.5 | -10.9 | -15.4 | -13.6 | -14.0 | -18.8 | -17.2 |
| EBIT margin | -23.1% | -59.3% | -125.9% | -149.0% | -107.7% | -114.8% | -164.6% | -90.8% |
| Pre-tax income | -4.2 | -6.5 | -11.1 | -15.5 | -13.6 | -14.0 | -19.1 | -17.7 |
| Income taxes | 0.1 | 0.1 | 0.1 | -0.1 | 0.2 | 0.1 | 0.1 | 0.1 |
| Tax rate | | | | 0.5% | | | | |
| Net income | -4.3 | -6.6 | -11.2 | -15.4 | -13.8 | -14.1 | -19.1 | -17.8 |
| Net margin | -26.4% | -52.2% | -129.2% | -149.8% | -109.1% | -116.3% | -167.7% | -94.2% |
| |
| Diluted EPS | ($0.34) | ($0.57) | ($1.14) | ($2.02) | ($2.16) | ($2.56) | ($0.29) | ($0.32) |
| Shares outstanding (diluted) | 12.6 | 11.5 | 9.8 | 7.7 | 6.4 | 5.5 | 65.4 | 56.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|